Boule Diagnostics AB (OTCPK:BDABF)
$ 7.84 0 (0%) Market Cap: 26.17 Mil Enterprise Value: 41.04 Mil PE Ratio: 0 PB Ratio: 1.08 GF Score: 69/100

Q2 2024 Boule Diagnostics AB Earnings Call Transcript

Jul 22, 2024 / 08:00AM GMT
Release Date Price: $7.84
Holger Lembrer
Boule Diagnostics AB - Chief Financial Officer

Good morning, everybody, and welcome to the second quarter's earnings call for Boule Diagnostic. I'm Holger Lembrér, CFO for Boule Diagnostics. And with me, I have our CEO, Torben Nielsen. After the presentation, we will open up for questions. So please raise your hand in teams if you would like to answer your question or write a question in the chat field.

With that I'm handing over to our CEO, Torben Nielsen.

Torben Nielsen
Boule Diagnostics AB - Chief Executive Officer

Thank you, Holger. Good morning, everyone, and thank you for joining our Q2 earnings call. I've now been in the role for close to 100 days. And we'd like to share my first impressions and thoughts on Boule and the direction we are setting out for Boule in the short to medium term.

Through the calendars and job training meetings I've had with team members across our organization, I've have learned that Boule is resting on a foundation of truly great people that are united by the desire to deliver quality

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot